AI辅助的胃镜下HP诊断系统的开发及应用

注册号:

Registration number:

ChiCTR2000037801 

最近更新日期:

Date of Last Refreshed on:

2020-11-07 14:52:34 

注册时间:

Date of Registration:

2020-09-02 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

AI辅助的胃镜下HP诊断系统的开发及应用

Public title:

Development and application of AI assisted HP diagnosis system under gastroscope

注册题目简写:

English Acronym:

研究课题的正式科学名称:

AI辅助的胃镜下HP诊断系统的开发及应用

Scientific title:

Development and application of AI assisted HP diagnosis system under gastroscope

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

邹佩颖 

研究负责人:

兰春慧 

Applicant:

Zou Pei-Ying 

Study leader:

Lan Chun-Hui 

申请注册联系人电话:

Applicant telephone:

+86 18502301305

研究负责人电话:

Study leader's
telephone:

+86 023 68757616

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

740177585@qq.com

研究负责人电子邮件:

Study leader's E-mail:

lanchunhui@tmmu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市渝中区长江支路10号

研究负责人通讯地址:

重庆市渝中区长江支路10号

Applicant address:

10 Changjiang Branch Road, Chongqing, China

Study leader's address:

10 Changjiang Branch Road, Chongqing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中国人民解放军陆军特色医学中心消化科

Applicant's institution:

Department of Gastroenterology, Army Medical Center of PLA (Daping Hospital)

研究负责人所在单位:

中国人民解放军陆军特色医学中心消化科

Affiliation of the Leader:

Department of Gastroenterology, Army Medical Center of PLA (Daping Hospital)

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

No.89,2020

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

陆军特色医学中心(大坪医院)伦理委员会

Name of the ethic committee:

The Ethics Committee of Army Medical Center of PLA (Daping Hospital)

伦理委员会批准日期:

Date of approved by ethic committee:

2020-07-10 00:00:00

伦理委员会联系人:

范士志

Contact Name of the ethic committee:

Fan Shizhi

伦理委员会联系地址:

重庆市渝中区长江支路10号

Contact Address of the ethic committee:

10 Changjiang Branch Road, Chongqing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

陆军特色医学中心消化科

Primary sponsor:

Department of Gastroenterology, Army Medical Center of PLA (Daping Hospital)

研究实施负责(组长)单位地址:

重庆市渝中区长江支路10号

Primary sponsor's address:

10 Changjiang Branch Road, Chongqing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

陆军特色医学中心(大坪医院)

具体地址:

渝中区长江支路10号

Institution
hospital:

Army Medical Center of PLA (Daping Hospital)

Address:

10 Changjiang Branch Road, Yuzhong District

经费或物资来源:

重庆市科卫面上项目,编号2018MSXM014

Source(s) of funding:

Chongqing Science-Health Joint Medical Research Project (No. 2018MSXM014).

研究疾病:

AI辅助的胃镜下HP诊断系统的开发及应用  

Target disease:

Development and application of AI assisted HP diagnosis system under gastroscope

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

(1)通过深度卷积神经网络学习构建幽门螺杆菌感染诊断人工智能系统 (2)应用该系统提高低年资内镜医师采集图像规范性及镜下诊断HP的能力  

Objectives of Study:

(1) Build an Artificial intelligence system for the diagnosis of helicobacter pylori infection through deep convolutional neural network learning (2) The system was used to improve the standardization of image collection and the ability of low experience of endoscopic physicians diagnosis of HP

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

(1)试验前四周内使用过PPI、抗生素、H2受体拮抗剂、铋剂、益生菌制剂等药物;
(2)妊娠或哺乳期妇女,研究期间有生育计划的患者;
(3)同时服用非甾体抗炎药、肾上腺皮质类固醇、抗凝药、酗酒;
(4)存在其它影响本研究评价的严重疾病如严重的肝病、心脏病、肾脏病、恶性肿瘤、精神疾病等,难以耐受胃镜检查患者;
(5)既往有过胃、十二指肠球部溃疡史,有胃部恶性肿瘤等其他胃内器质性病变;
(6)前三个月内参加过其它药物研究;
(7)难以完成随访或存在影响依从性的其他因素。

Exclusion criteria:

(1) proton pump inhibitor , antibiotics, histamine-2 receptor antagonist , bismuth, probiotics and other drugs were used within four weeks before the test;
(2) Pregnant or lactating women, patients with family planning during the study period;
(3) At the same time, they took NSAIDs, corticosteroids, anticoagulants and alcoholism;
(4) There are other serious diseases that affect the evaluation of this study, such as severe liver disease, heart disease, kidney disease, malignant tumor, mental disease, etc., which are difficult to tolerate gastroscopy;
(5) He had a history of gastric and duodenal ulcer, gastric malignant tumor and other gastric organic lesions;
(6) Participated in other drug research in the first three months;
(7) It is difficult to complete the follow-up or there are other factors affecting the compliance.

研究实施时间:

Study execute time:

From 2020-09-26 00:00:00 To 2021-05-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-09-26 00:00:00 To 2021-05-31 00:00:00

干预措施:

Interventions:

组别:

AI组VS无AI组

样本量:

800

Group:

AI group vs non-AI group

Sample size:

干预措施:

干预措施代码:

Intervention:

Nil

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

陆军特色医学中心(大坪医院) 

单位级别:

三甲 

Institution
hospital:

Army Medical Center of PLA (Daping Hospital)

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

检出率

指标类型:

主要指标

Outcome:

Detection rate

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

准确性

指标类型:

主要指标

Outcome:

accuracy

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

敏感性

指标类型:

主要指标

Outcome:

sensitivity

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

特异性

指标类型:

主要指标

Outcome:

specificity

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

内镜操作时间

指标类型:

次要指标

Outcome:

Endoscopic operation time

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

早癌检出率

指标类型:

次要指标

Outcome:

early gastric cancer of detection rate

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

胃黏膜

组织:

Sample Name:

Gastric mucosa

Tissue:

stomach

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 70 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

按电脑生成的随机数字序列来进行区组数为2的区组随机化分组。

Randomization Procedure (please state who generates the random number sequence and by what method):

A computer-generated permuted block randomisation sequence with a block size of two was used for randomisation.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

未说明

Blinding:

Not stated

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

电子邮件

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Email contact

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用纸质病例报告表以及Excel表格采集和管理数据

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The preservation and management of raw data using the paper case report form and excel form.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2020-09-02 02:57:08